Thursday, November 18, 2021
Print Current Session:
|
|
Thursday
SESSION 61:
NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ANGIOPLASTY BALLOONS
|
|
SESSION 61 SCHEDULE | |
3:24 PM - 3:29 PM | Chocolate Touch DCBs (From TriReme Medical): How Do They Work, Advantages And Updated Clinical Results |
Presenter(s):Andrew Holden, MBChB Location: Grand Ballroom West, 3rd Floor |
|
3:30 PM - 3:35 PM | Value Of High-Pressure Non-Compliant Balloons For BTK Arterial Lesion Treatment: Why They Work Better And Other Technical Tips |
Presenter(s):Steven Kum, MD Location: Grand Ballroom West, 3rd Floor |
|
3:36 PM - 3:41 PM | Update On The TANGO Trial Using The Bullfrog Balloon Device (Mercator Medical Systems) To Inject Sirolimus Drug Into Lesion Wall Before Angioplasty: How Does It Work And Results |
Presenter(s):Ehrin Armstrong, MD Location: Grand Ballroom West, 3rd Floor |
|
3:42 PM - 3:47 PM | Value Of The Passeo-18Lux DCB For Treating BTK Lesions With Or Without Bare Metal Stents |
Presenter(s):Gunnar Tepe, MD Location: Grand Ballroom West, 3rd Floor |
|
3:48 PM - 3:53 PM | Unfavorable Balloon Wrap (Candy) Cause Dissections With Angioplasty: What Is The Mechanism: How Can It Be Recognized And Dissection Avoided: The Chocolate DCB Is One Way |
Presenter(s):Jos C. van den Berg, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
3:54 PM - 3:59 PM | The Importance Of Dissection In Angioplasty Treatment Of BTK Lesions: How To Prevent And Treat Such Dissections: The Value Of Tacks (From Intact Vascular): How Do They Work |
Presenter(s):Andrew Holden, MBChB Location: Grand Ballroom West, 3rd Floor |
|
4:00 PM - 4:05 PM | 12-Month Results Of TOBA II BTK Trial Of The Tack Device To Decrease Dissections With Balloon Angioplasty Of BTK Lesions Show Safety And 80% Patency |
Presenter(s):Patrick J. Geraghty, MD Location: Grand Ballroom West, 3rd Floor |
|
4:06 PM - 4:12 PM | Panel Discussion |
END OF SESSION 61 | |
previous | next |